» Articles » PMID: 7540999

Acute Hypercalcemia Causes Acute Pancreatitis and Ectopic Trypsinogen Activation in the Rat

Overview
Specialty Gastroenterology
Date 1995 Jul 1
PMID 7540999
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Background & Aims: Clinical and experimental observations have associated acute and chronic hypercalcemia with pancreatitis. The aim of this study was to determine whether acute hypercalcemia can induce acute pancreatitis and, if so, whether the pathogenesis involves premature protease activation.

Methods: Rats given bolus infusions of CaCl2 (200 mg/kg; n = 76) were compared with saline-treated controls (n = 40). Serum [Ca2+], serum amylase activity, trypsinogen activation peptide (TAP) concentration in serum and pancreatic tissue, pancreatic wet/dry weight ratio, and histology were assessed for 24 hours. For dose-response analysis, CaCl2 was injected at a dose of 50-200 mg/kg, and the aforementioned indices were assayed for 1 hour (n = 5 each).

Results: There were no significant changes in the controls. Calcium infusion increased serum [Ca2+] 3-fold after 5 minutes (P < 0.001). Within 1 hour, serum amylase (2.5-fold) and tissue TAP (3-fold) levels increased along with macroscopic and microscopic edema formation and leukocytic infiltration. The extent of the changes at 1 hour correlated with the calcium dose. Amylase and tissue TAP concentrations remained elevated until 24 hours when serum TAP concentration had increased (P < 0.001) and focal acinar necrosis became evident.

Conclusions: Acute experimental hypercalcemia induces dose-dependent morphological alterations characteristic of acute pancreatitis, acute hyperamylasemia, and early ectopic trypsinogen activation. This supports the pathophysiological relevance of excess calcium and offers a possible pathogenetic mechanism for its association with clinical pancreatitis.

Citing Articles

Elimination of intracellular Ca overload by BAPTA‑AM liposome nanoparticles: A promising treatment for acute pancreatitis.

Fu Z, Wang D, Zheng C, Xie M, Chen Y, Zhou Y Int J Mol Med. 2024; 53(4).

PMID: 38390952 PMC: 10903929. DOI: 10.3892/ijmm.2024.5358.


Investigation of the potential association between the use of fluoxetine and occurrence of acute pancreatitis: a Danish register-based cohort study.

Aakjaer M, Kristiansen S, Pape K, Sessa M, Dalhoff K, De Bruin M Int J Epidemiol. 2022; 51(5):1656-1665.

PMID: 35472246 PMC: 9558065. DOI: 10.1093/ije/dyac071.


Common calcium-sensing receptor (CASR) gene variants do not modify risk for chronic pancreatitis in a Hungarian cohort.

Takats A, Berke G, Szentesi A, Farkas Jr G, Izbeki F, Eross B Pancreatology. 2021; 21(7):1305-1310.

PMID: 34481716 PMC: 8663126. DOI: 10.1016/j.pan.2021.08.012.


Three pediatric patients with primary hyperparathyroidism caused by parathyroid adenoma.

Oh A, Lee Y, Yoo H, Choi J Ann Pediatr Endocrinol Metab. 2021; 27(2):142-147.

PMID: 34015897 PMC: 9260372. DOI: 10.6065/apem.2142006.003.


Frequency & predictors of pancreatitis in symptomatic primary hyperparathyroidism.

Arya A, Bhadada S, Mukherjee S, Singh P, Rana S, Dahiya D Indian J Med Res. 2019; 148(6):721-727.

PMID: 30778006 PMC: 6396558. DOI: 10.4103/ijmr.IJMR_353_16.